August Newsletter
A Widening Gap – Fewer Donor Hearts for More Children Waiting
April Newsletter
December Newsletter
Partial Heart Transplantation: A Growing Solution for Pediatric Valve Disease
October Newsletter
Continuous Distribution for Heart Allocation: Promise, Challenges, and the Path Forward
May Newsletter
Statin Use for CAV Prevention in Pediatric Heart Transplant Recipients: Helpful or Harmful?
February Newsletter
The Utility of Early Aspirin Use and the Development of Pediatric Cardiac Allograft Vasculopathy
Enhancing Wellbeing in Pediatric Heart Transplantation Providers
Success through Commitment and Collaboration
Duchenne Muscular Dystrophy: Current Strategies, and What’s On the Horizon
Desperate times can facilitate important innovation – the evolution of ABO incompatible heart transplantation in children.
The 2023 OPTN ABO-incompatible heart transplantation policy changes explained
July Newsletter
Thoughts from Incoming Fourth Year Fellows
New Academic Year, New Chapter
Unintended consequences? – Policy changes and equity in pediatric heart transplantation
Bias in Pediatric Cardiac Transplantation
January Newsletter
Decisions, Decisions, Decisions…The Challenges Between Two Different Organ Allocation Systems
Creating a Culture of “Yes” in Pediatric Heart Donation
Donor-derived Cell-free DNA (dd-cfDNA) – The Latest Tool in the World of Pediatric Heart Transplant
The Molecular Microscope Diagnostic System: What Is It and How Are We Using It in Our Patients?
The World’s First Pig-to-human Heart Xenotransplant: Where is this Going?
Current Trends in Coronary Artery Vasculopathy
September Newsletter
Implementation of ABO Incompatible Heart Transplant Program in Spain
ABO-Incompatible Heart Transplantation
Panorama-HF Trial Invited Article
TEAMMATE Trial Invited Article
Covid-19 Invited Article
Summer Newsletter
Fall Newsletter
Winter Newsletter
Spring Newsletter